Biological and Medicinal Importance of Sponge by Amina, Musarat & Al Musayeib, Nawal M.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Biological and Medicinal Importance of Sponge
Musarat Amina and Nawal M. Al Musayeib
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.73529
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
s r t  i   l .  l s y i
Additional infor ation is available at the end of the chapter
Abstract
Sponges are multicellular, heterotrophic parazoan organisms, characterized by the pos-
session of unique feeding system among the animals. They are the most primitive types of 
animals in existence, featuring a cell-based organization where different cells have different 
tasks, but do not form tissues. Sponges (Porifera) are a predominantly marine phylum liv-
ing from the intertidal to the abyssal (deepest ocean) zone. There are approximately 8500 
described species of sponges worldwide with a prominent role in many reef coral communi-
ties. Several ecological studies reported have shown that secondary metabolites isolated from 
sponges often serve defensive purposes to protect them from threats such as predator attacks, 
biofouling, microbial infections, and overgrowth by other sessile organisms. In the recent 
years, interest in marine sponges has risen considerably due to presence of high number of 
interesting biologically active natural products. More than 5300 different natural products are 
known from sponges and their associated microorganisms, and every year hundreds of new 
substances are discovered. In addition to the unusual nucleosides, other classes of substances 
such as bioactive terpenes, sterols, fatty acids, alkaloids, cyclic peptides, peroxides, and amino 
acid derivatives (which are frequently halogenated) have been described from sponges or 
from their associated microorganisms. Many of these natural products from sponges have 
shown a wide range of pharmacological activities such as anticancer, antifungal, antiviral, 
anthelmintic, antiprotozoal, anti-inflammatory, immunosuppressive, neurosuppressive, and 
antifouling activities. This chapter covers extensive work published regarding new com-
pounds isolated from marine sponges and biological activities associated with them.
Keywords: sponges, anticancer, antibacterial, chemical constituents
1. Introduction
Sponges are the ancient, efficient designed multicellular parazoan organisms and show rela-
tively little differentiation and tissue coordination. A sponge is a sessile, sedentary, filter-feeding 
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primitive aquatic invertebrate animal which attaches itself to solid surfaces from intertidal zone 
to depths of 29,000 ft (85000m) or more, where they can get sufficient food to grow [1, 2]. Sponges 
feed on microscopic organisms (protozoa, bacteria and other small organisms in water) and 
organic particles [3]. There are about 10,000 known species inhabit a wide variety of marine and 
fresh water habitats and are found throughout deep ocean depths to rock pools, warm tropical 
seas to frozen arctic seas, rivers and streams [3, 4]. They are very diverse and occur in various col-
ors, sizes and shapes such as tubular (tube-like), globular (ball-shaped), caliculate (cup-shaped), 
arboresecent (plant-shaped), flabellate (fan-shaped) and amorphous (shapeless). The scientific 
term for sponges is Porifera meaning “pore-bearing” and has bodies full of pores and channels 
allowing water to circulate through them, consisting of jelly-like mesohyl sandwiched between 
two layers of cells [5]. The shapes of their bodies are adapted for maximal efficiency of water 
flow through the central cavity, where it deposits the nutrients, and leaves through a hole called 
the osculum. Several sponges have spicules of silicon dioxide or calcium carbonate and a mesh 
of proteins called spongin as an internal skeleton. One of the remarkable properties of sponges 
is their ability to suffer damage and regenerative capacity [6–8]. Marine sponges have attracted 
growing attention as a source of overwhelming structurally diverse secondary metabolites with 
potential biological activities and were placed at the top with respect to discovery of biologi-
cally active chemical constituents [9, 10]. Although thousands of chemical compounds have been 
reported in the literature from these sponges, only few of them are clinically described. Many 
studies revealed that sponge-derived metabolites are used directly in therapy or as a prototype 
of bioactive leads to develop more active and less toxic analogs [11, 12]. Sponges are most primi-
tive type of aquatic animals in existence which are dominating many benthic habitats, featur-
ing a cell-based organization where different cells conduct all forms of bodily function, but do 
not form tissues [13]. They consume food and excrete waste products within cells without a 
body cavity [14]. Several ecological studies reported that high quantity of bioactive constituents 
produced by sponges often serve defensive against environmental threats such as predation, 
microbial infection, competition for space or overgrowth by fouling organisms [15, 16]. For this 
reason marine sponges are the subject of attraction for chemists due to the sheer number of 
metabolites produced, the novelty of structure encountered, and the therapeutic potential of 
these compounds in the treatment of human diseases. Scientists working in the field of natural 
product chemistry and research suggest that these sponges have promising potential to provide 
future drugs which can serve various diseases. In this chapter, we describe main isolated chemi-
cal entities from sponges and their pharmacological application.
2. Anticancer agents
In the recent years, marine natural products bioprospecting has yielded a considerable num-
ber of drug candidates, most still being in preclinical or early clinical development, with only 
a limited number already in the market [17]. A typical example of marine anticancer drugs is 
eribulinmesylate, a derivative of halichondrin B isolated from the marine sponge. Halichondria 
okadai has achieved success in phase III clinical trials. Literature studies have shown sponge-
derived discodermolides antitumor compounds can play remarkable role in future to treat 
cancer. Plethora of secondary metabolites is produced by marine sponges and their symbionts. 
The spongothymidine and spongouridine nucleosides were the first successful sponge-derived 
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pharmaceutical drugs isolated from Tectitethya crypta [18]. Ara-C (cytarabineor1-beta-D-Arabi-
nofuranosylcytosine) recently used for the cure of leukemia [19, 20] and its combination with 
Daunoribicin and other anticancer drugs, is screened in clinical trials for the treatment of acute 
myeloid neoplasms [21] During the last few years several marine derived natural compounds 
are in the pipeline for evaluation in Phase I–III clinical trials for various cancers treatment 
[22]. A review in 2003 listed the most important anticancer candidate from marine natural 
compounds undergoing preclinical and clinical (I, II, III) trials and following compounds 
were from sponge origin: Isohomohalichondrin B, Halichondrin B, Laulimalide/Fijianolide,5-
methoxyamphimedine(alkaloid)Discodermolide, Hemiasterlins A and B, Fascaphysins (alka-
loid), modified halichondrin B, KRN-70000, Alipkinidine (alkaloid), and Variolin (alkaloid) 
[23]. Moreover marine sponges are the important source for vital diverse bioactive constit-
uents including alkaloids, terpenoids, sterols and macrolides. Renieramycins, members of 
tetrahydroiso-quinoline family were isolated from marine sponges from genus Reniera with 
promising anticancer potential. The preclinical results reported that Renieramycin M, a natu-
ral constituent from sponge induced lung cancer cells apoptosis through p53-dependent path-
way and may inhibit progression and metastasis of lung cancer cells [24]. A novel polycyclic 
guanidine alkaloid monanchocidin isolated from Monanchora pulchra marine sponge reported 
to induce cell death in human cervical cancer (HeLa),human monocytic leukemia (THP-1)
and mouse epidermal (JB6 Cl41) cells [25]. In the early 1987, as esquiterpene aminoquinone, 
Smenospongine extracted from Smenospongia sp. reported to induces cytotoxic, antiprolife-
retive, antiangiogenic, and antimicrobial activities [26]. Spongistatin a macrocyclic lactone 
polyether isolated from Spongia sp. marine sponge in 1993 was shown to inhibit microtubule 
assembly, mitosis, and the binding of tubulin to vinblastine thereby inducing cytotoxic cell 
death in numerous cancer cell lines [27, 28]. Recently a very important compound named lec-
tin has been isolated from Cinachyrella apion marine sponge was evaluated for antiproliferative, 
hemolytic, and cytotoxic properties, besides the ability to induce cell death in tumor cells. 
Results showed that the lectin induces cell death by apoptosis activation by pro-apoptotic pro-
tein Bax, promoting permeabilization of mitochondrial membrane, S phase cell cycle arrest 
and acting as both dependent and/or independent of caspases pathway. These results indicate 
the potential of lectin for treating cancer [29]. Another marine sponge component, heterone-
min a sesterterpene isolated from Hyrtios sp. has attracted the interest of researchers as an anti-
mour agent especially for its pharmacological effects on chronic myelogenous leukemia cells. 
Results revealed that heteronemin affected the various cellular processes such as cell cycle, 
nitrogen-activated protein kinases pathways, apoptosis, and nuclear factor kappa B signaling 
cascade. Thus the compound has shown anti-inflammatory as well as anticancer agent [30]. A 
collaborative program between experimental therapeutics laboratory of Henry Ford Hospital 
in Detroit and University of California Santa Cruz initiated in 1990 focused on the develop-
ment and discovery of anticancer drugs from sponge extracts. About 2036 extracts from 683 
individual sponges were examined by using novel in vitro assay led to the identification pure 
bioactive compounds from many sponges for treating solid tumors. The collaborative efforts 
and analogs led to the isolation of number of constituents with of anticancer potential [31].
Thus the possibility of development of new anticancer drugs for curing or reducing cancer is 
promising. Until now, in vitro antitumor activity studies of sponge-derived compounds were 
tested. Thus, the detailed pharmaceutical studies to investigate the mechanism of action and clin-
ical trials are needed. Moreover, the extensive ongoing research on sponges and development 
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of new advanced techniques have made it possible to access deep sea, new anticancer marine 
isolates with unprecedented carbon skeleton and inhibitory activities of human cancer cell con-
tinued to be discovered and developed, which will offer in future the new candidate for cancer 
therapy. The chemical constituents so far reported for anticancer activity include (Table 1).
Categories Species Active agents Antitumor tested References
Alkaloids Papua Hyrtiocarboline H522-T1, MDA-MB- 435, U937 tumor cell lines [31]
Penares sp. HL-60, HeLa [32]
Aaptos suberitoides Aaptamine L5178Y [33]
Monanchora arbuscula Norbatzelladine
Dinorbatzelladine MDA-MB-231 breast cancer [34]
Dinordehy-drobatzelladine
Dinorbatzelladine
Dihomodehy-drobatzelladine MDA-MB-231 breast cancer [34]
Clathria calla Norbatzelladine
Clathriadic acid
Xestospongia sp. Renieramycin T HCT116, QC56, AsPC1 [35]
T47D tumor cell lines
Smenospongia sp. 6′-Iodoaureol MOLT-3, HepG2 cells [36]
Hyrtios sp. Hyrtimomine A Human epidermoid carcinoma KB, murine 
leukemia L1210
[37]
Pseudoceratina verrucosa Aplysamine HeLa, NFF cells [38]
Amphimedon sp. Pyrinodemin G P388 murine leukemia cells
Pyrinodemin H [39]
Oceanapia sp. Sagitol C PC12, L5178Y, HeLa cells [40]
Monanchora pulchra Monanchocidins B




Agelestes A-B U937, PC9 human
(9S, 10R, 90S, 100R)-nakamuric 
acid
Cancer cell lines [42]
Sterols Ianthella sp. Petrosterol-3,6-dione A549 (lung), HT-29 (colon),
5α,6α-epoxy-petrosterol SK-OV-3 (ovary), MCF-7 (breast) HL-60 and 
U937
[43]
Lissodendryx fibrosa Manadosterol A-B Ubc13–Uev1A complex [44]
Terpenoids Carteriospongia sp. Homoscalarane sesterterpenes A2780, H522-T1, A2058 [45]
Monanchora sp. 9Sesterterpenoids A498, ACHN (renal cancer) [46]
MIA-paca, and PANC-1 (pancreatic cancer) [47]
Psammocinia sp. Scalarane sesterterpenes A498, ACHN MIA-paca,PANC-1 [48]
Pseudoaxinella flava Diterpene isonitrile PC3(prostate cancer cell line) [49]
Agelas axifera Three axistatins (pyrimidine 
diterpenes)
P338, BXPC-3 MCF-7, SF-268 NCI-H460, 
KML20L2, and DU-145 cell lines growth
[50]
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Categories Species Active agents Antitumor tested References
Thorectare ticulate Metachromins U
Metachromins V
SF-268, H460,MCF-7, HT-29, and CHOK1 
(mammalian cell line)
[51]
Dactylospongia elegans Nakijinol B and CHO-K1 SF-268, H460, MCF-7, HT-29 [51]





Macrolide Cinachyrella enigmatica Enigmazole A NCI 60 human tumor cells [54]




Mycale hentscheli Peloruside A P388 HL-60 cells [56]
Peloruside B
Pipestela candelabra Pipestelide A KB cell lines [57]
Pipestelide B
Polyketone Plakortis simplex Simplextone C HeLa, K562, A-549 cell lines
Plakortoxide A [58]
Plakortis halichondrioides Epiplakinidioic acid DU-145, A2058 [59]
Plakortoxide A tumor cell lines
Lithoplocamialithistoides Polyketides PM050489 HT-29, A549, MDA-MB-231
Polyketides PM060184 Human tumor cell lines [60]
Peptides Homophymia sp. Homophymines B KB, MCF7, MCF7R, HCT116
Homophymines E HCT15, HT29, OVCAR 8, OV3,
Homophymines A1-E1 PC3, Vero, MRC5, HL60, HL60R, K562, PaCa, 
SF268, A549, MDA231, MDA435, HepG2, and 
EPC human tumor cells
[61]
Neamphius huxleyi Neamphamide B A549,HeLa, LNCaP,
Neamphamide C PC3, NFF human tumor
Neamphamide D cell lines [62]
Eurypon laughlini Rolloamide A LNCap, PC3MM2, PC3, DU145 (Prostrate), 
MDA361, MCF7, MDA231 (breast), OVCAR3, 
SKOV3, U87MG (Glioma), (ovarian), A498 
(renal)
[63]
Stylissa caribica Stylissamide H HCT-116. [64]
Homophymia lamellose Pipecolidepsin A A549, HT-29 MDA-MB-231
Pipecolidepsin B Human tumor cells [65]
Glycosides Pandaros acanthifolium Acanthifoliosides A–E L6 cell lines [66]
Rhabdastrella globostellata Rhabdastin E-G HL-60 [67]
Quinones Dysidea avara Dysidavarone A HeLa, A549, MDA231, QGY7703
Dysidavarone D HeLa tumor cells [68]
Dactylospongia 
metachromia
5 Sesquiterpene aminoquinones L5178Y mouse cancer cell lines [69]
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3. Antibacterial active agents
Marine sponges are among the richest sources of interesting chemicals produced by marine organ-
isms. Exploitation of bioactive metabolites by natural product chemist from marine sources by 
using antimicrobial or cytotoxic assays started back in 1970s. Later, various reputed pharmaceuti-
cal companies joined hands for this effort using more advance assay systems, including enzyme 
inhibition assays. As a result several new promising bioactive candidates have been discovered 
from marine sponges [76]. Bioactive constituents are claimed for potent in vivo or in vitro activity 
against infectious and parasitic diseases, such as bacterial, fungal, viral and protozoan infections. 
Studies revealed that the crude extracts of marine sponge have shown high incidences of anti-
bacterial activity against terrestrial pathogenic bacteria, but very low incidences of antibacterial 
activity against marine bacteria [77, 78]. Very few cases of sponge infection by exogenous micro-
organisms are known, presumably due to the accumulation/or product by the marine sponges 
of substances which have antimicrobial activity [1]. A number of new metabolites with antibi-
otic applications are discovered every year, but in marine sponges their ubiquity is remarkable. 
Antibacterial screening of marine sponges led to identification and characterization of wide range 
of active chemical constituents, including some with promising therapeutic leads [79, 80]. Around 
850 antibiotic constituents are reported from marine sponges [81]. Various antibacterial substances 
were identified from marine sponges by continuous efforts of marine natural product community. 
Despite of discovery of huge number of natural product from marine sponges, none of them has 
yet led to antibacterial product, but currently several are under investigation. Examples of some 
isolated substances from marine sponges with antibacterial activity are shown in Table 2. The 
first discovered antibiotic from a marine sponge was manoalide, a seterterpenoid isolated from 
Luffariella variabilis [82]. The most promising constituents with antibacterial properties reported 
from marine sponges include: agelasine D, cribrostatin 3 and 6, petrosamine B, psammaplin A and 
alkylpyridines (haliclonacyclamine E, arenosclerins) and among these constituents, manzamine A 
and psammaplin A are in preclinical trials. Many of these have excellent potential for drug devel-
opment, but no commercial medication has been originated from them so far.
Categories Species Active agents Antitumor tested References
Dactylospongia avara 3 Dysideanones A–C HeLa HepG2 cancer cell lines [70]
Miscellaneous Petrosia sp. 3(−) Petrosynoic acids A–D A2058, H522-T1,
H460 human tumor cell line
IMR-90 human fibroblast cells [71]
Subereamollis Subereaphenol D HeLa cell lines [72]







Myrmekioderma dendyi Myrmekioside E-2 NSCLC-N6 and A549 tumor cell lines [74]
Genus Suberea. Four novel Psammaplysin 
analogs
Cytotoxicity [75]
Table 1. Marine sponge-derived anticancer compounds and their effects.
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4. Antiviral compounds and their efficacy
The search for new antiviral substances from marine sources led to the isolation of several 
promising therapeutic leads which are presented in Table 3. The literature presents a good 
number of reports about different biological activities of marine sponges. Several papers 
Categories Species Active agents Antibacterial tested References
Alkaloids Axinella sp. Axinellamines B-D H. pylori Gram-(-ve) [83]
Acanthostrongylophora sp. 12,34-Oxamanzamine E, M. tuberculosis [84]
8-Hydroxymanzamine J
6-Hydroxymanzamine E
Arenosclera brasiliensis Haliclonacyclamine E, S. aureus, P. aeruginosa
Arenosclerins A-C [85]




Cribrochalina sp. Cribrostatin 3 N. gonorrheae [87]
Cribrochalina sp. Cribrostatin 6 S. pneumonia [88]
Spongosorites sp. Hamacanthin A S. aureus (MRSA strain) [86]
Oceanapia sp. Petrosamine B H. pylori [89]
Latrunculia sp. Discorhabdin R S. aureus, M. luteus
S. marcescens, E. coli
[90]
Hamacantha sp. Hamacanthin A 1 C. albicans
Hamacanthin B 2 C. neoformans [91]
Nitrogenous Pachychalina sp. Cyclostellettamines A-I, S. aureus (MRSA strain), [92]
Cyclostel K-L P. aeruginosa (antibiotic-resistant strain), M. 
tuberculosis
[93]
Pachychalina sp. Ingenamine G S. aureus (MRSA strain)
E. coli, M. tuberculosis [92]
M. sarassinorum Melophlin C B. subtilis, S. aureus [47]
Agelas sp. Agelasine D M. tuberculosis Gram  
(+ve, -ve)
[94]
Terpenoids Cacospongia sp. Isojaspic acid, cacospongin D, 
jaspaquinol
S. epidermidis [95]
Myrmekiodermastyx (S)-(+)-curcuphenol M. tuberculosis [96]
Miscellaneous Oceanapia sp. C14 acetylenic acid E. coli, P. aeruginosa, B. subtilis, S. aureus [97]
C. sphaeroconia Caminosides A-D E. coli [98]
A. coralliphaga Corallidictyals A-D S. aureus [99]
C. varians CvL B. subtilis, S. aureus [100]
N. magnifica Latrunculins S. aureus and B. cereus [101]
Discodermia sp. Polydiscamide A B. subtilis [93]
Psammaplysilla Psammaplin A S. aureus (MRSA strain) [102]
Table 2. Marine sponge-derived antibacterial compounds and their effects.
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reports the screening results of marine organisms for antiviral activity, and a diverse range 
of active constituents have been isolated and characterized from them [80, 103, 104]. For some 
of these isolated substances important antiviral activities were reported. Perhaps the most 
important antiviral lead of marine origin reported thus far is the nucleoside ara-A (vidarabine) 
isolated from the sponge Cryptotethya crypta. Ara-A is a semisynthetic compound, based on the 
arabinosyl nucleosides, that inhibits viral DNA synthesis [105]. Once it was realized that bio-
logical systems would recognize the nucleoside base after modifications of the sugar moiety, 
chemists began to substitute the typical pentoses with acyclic entities or with substituted sug-
ars, leading to the drug azidothymidine (zidovudine). Ara-A, ara-C (1-β-Darabinosyl cytosine, 
cytarabine), acyclovir, and azidothymidine are in clinical use and are all examples of products 
of semisynthetic modifications of the arabinosyl nucleosides [106]. Several of these substances 
have a great potential for drug development. Ara-A has been used for the treatment of herpes 
virus infections, but it is less efficient and more toxic than acyclovir [107, 108]. However, ara-A 
is capable of inhibiting a cyclovir-resistant HSV and VZV (varicella-zoster virus) [109]. The 
most promising antiviral substances from sponges appear to be 4-methylaaptamine, avarol, 
manzamines, mycalamide A and B. Among these substances, preclinical assessments were 
started for avarol and manzamine A. In general, antiviral molecules from sponges do not give 
protection against viruses, but they may result in drugs to treat already infected individuals. 
In addition, broad-based antiviral agents such as 2-5A and α-glucosidase inhibitors may be 
useful in cases of sudden outbreaks of (less familiar) viruses such as SARS and Ebola [80].
Categories Species Active agents Antiviral tests References
Alkaloid Aaptosa aptos 4-Methylaaptamine HSV-1 [110]
Halicortex sp. Dragmacidin F HSV-1 [111]
Indo-Pacific Manzamine A, 8-hydroxymanzamine A, 
6-deoxymanzamine X neokauluamine
HIV-1 [112]
Nucleosides Mycale sp. Mycalamide A-B A59 coronavirus, HSV-1 [113]
Hamacantha sp. Coscinamides 60-62,
Chondriamides 63-65 Anti-HIV [91]
Cyclic depsipeptides Theonella sp. Papuamides A-D HIV-1 [114]
S. microspinosa Microspinosamide HIV-1 [115]
Sterols Haplosclerid sponges Haplosamates A HV-1
Haplosamates B [116]
Terpenoids D. avara Avarol 6′-hydroxy avarol, 3′-hydroxy 
avarone
HV-1 [117]
Nucleoside Cryptotethya crypta Ara-A HSV-1, HSV-2, VZV [105]
Mycale sp. Mycalamide A-B A59 coronavirus, HSV-1 [118]
Miscellaneous Dysidea avara Callyspongymic acid HIV, hepatitis B virus [119]
2′-5′ Oligoadenylates Viral replication [120]
H. tarangaensis Hamigeran B Herpes, polio viruses [121]
Petrosia weinbergi Weinbersterols A-B Leukemia virus, mouse influenza 
virus, mouse corona virus
[122]
Table 3. Antiviral compounds from marine sponges and their effects.
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5. Antifungal compounds
Marine sponges have been considered a gold mine for the discovery of marine natural products 
during the past 50 years. The need of new antifungals in clinical medicine due to various kinds of 
mycoses, in particular invasive mycoses have become serious health problems as their incidences 
has increased dramatically during last few years in relation to AIDS, transplant recipients, hema-
tological malignancies, transplant recipients and other immunosuppressed individuals. One of 
the major causes of death in patients suffering from malignant disease is fungal infections and 
emerging resistance is also an important problem. Immunocompromised patients are mainly 
infected by Aspergillus, Cryptococcus, Candida, and other opportunistic fungi. Candida albicans is 
most often associated with serious invasive fungal infections, but other Candida species and yeast-
like organisms (Blastoschizomyces, Trichosporon and Malassezia) have emerged as etiological agents 
of severe mycoses problem [123–126]. Fungicides which are presently being used are less diverse 
than antimicrobials, and the usage of many of them is restricted because of their toxic effects to 
animals, plants and humans. Moreover the progress in this area is slow as comparison to anti-
bacterial agents [126]. Antifungal compounds isolated from marine sponges are listed in Table 4.
Categories species Active agents Antifungal tests References
Alkaloids A. brasiliensis Arenosclerins A-C C. albicans
Haliclonacyclamine E [127]
Acanthostrongylophora sp. Manzamine A C. neoformans [112]
Leucetta cf. Naamine D Chagosensis C. neoformans [128]
Pseudoceratina sp. Ceratinadins A-C C. albicans [129]
A. citrina (−)-Agelasidine F, C. albicans
(−)-Agelasidine C [130]
M. arbuscular Batzelladine L A. flavus [131]
Terpenoids L. variabilis Secomanoalide C. glabrata, C. krusei
C. albicans [132]
M. herdmani Microsclerodermins A-B A. fumigatus [133]
Hyrtios sp. Puupehenonol C. neoformans, C. krusei [134]
Sterols Euryspongia sp. Eurysterols A-B C. albicans [135]
Topsentia sp Geodisterol-3-O-sulfite, 
29-demethylgeodisterol-3-OCl-sulfite
S. cerevisiae, C. albicans
C. albicans [136]
Peptides Discodermia sp. Discobahamin A-B C. albicans [137]
Jaspis sp. Jasplakinolide or jaspamide C. albicans [138]
Latrunculia sp. Callipeltins F-I C. albicans [139]
Latrunculia sp. Callipeltin J-K C. albicans [42]
T. swinhoei Theonellamide G C. albicans [140]





Agelas sp. Agelasines, agelasimines C. krusei [142]




Marine organisms and microorganisms have provided a large proportion of the anti-inflamma-
tory and natural antioxidants products over the last years. Reports suggest that marine inver-
tebrates represent new marine resources for the isolation of novel agents which are active on 
inflammatory conditions have also been found in the literature. Herencia and coworkers [156] 
studied the effects of dichloromethane and methanol extracts from some Mediterranean marine 
invertebrates on carrageenan-induced paw edema in mice. Extracts partially decreased elas-
tase activity and PGE2 levels measured in homogenates from inflamed paws, without affecting 
the levels of this prostanoid present in stomach homogenates. Within the framework of the 
European MAST III Project, extracts of different polarity from sponges, ascidians and cnidar-
ians have been screened for immunomodulating activities [157]. It was demonstrated that endo-
toxin-free samples of marine origin possess effects on certain components of the immune system. 
As a result of all these investigations, bioassay-directed separation of active extracts identified 
many structurally diverse compounds as future leads. Anti-inflammatory compounds found in 
the marine environment include terpenes and steroids, alkaloids, peptides and proteins, poly-
saccharides and others. Examples of anti-inflammatory compounds marine sponge origin are 
presented in Table 5. Also includes diterpenes of (8E, 13Z, 20Z)-strobilinin and (7E, 13Z, 20Z)-
felixinin from a marine sponge Psammocinia sp. [158], and novel anti- inflammatory spongian 
diterpenes from the New Zealand marine sponge Chelonaplysill aviolacea [159].
Categories species Active agents Antifungal tests References
Miscellaneous P. reticulate Crambescin A2 392 C. albicans
Crambescin A2 406 C. neoformans var. gattii,
Crambescin A2 420 C. glabrata, C. krusei
Sch 575948 [143]
Sponge Theonellamides Antifungal [144]
Melophlus sp. Aurantoside K C. albicans (wild-type) [145]
P. halichondrioides Plakortide F C. albicans, C. neoformans, A. 
fumigatus
[146]




P. onkodes Two α and β1,2-dioxolane peroxide acids C. albicans [149]
T. laevispirulifer Nematocide, onnamide F S. cerevisiae [150]
T. swinhoei Swinhoeiamide A C. albicans, A. fumigates [151]
Family Neopeltidae Neopeltolide C. albicans [152]
Plakinastrella Epiplakinic acid F C. albicans [153]
H. communis (−)-Untenospongin B C. albicans, C. tropicalis,  
F. oxysporum
[154]
H. lachne Hippolachnin A C. neoformans, T. rubrum, M. 
gypseum
[155]
Table 4. Antifungal compounds from marine sponges and their effects.
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7. Marine sponge-derived compounds with enzyme inhibitory activity
Derivatives of halenaquinone and xestoquinone showed various enzyme inhibitory activities 
besides the phosphatidylinositol 3-kinase and topoisomerase I and II inhibitory activities men-
tioned above. Compound xestoquinone inhibited both Ca2+ and K+-ATPase of skeletal muscle 
myosin [185]. SAR Investigations showed that halenaquinone and three synthetic analogs with 
a quinone structure significantly inhibited Ca2+ ATPase activity. In contrast, four xestoquinone 
Categories species Active agents Anti-inflammatory tests References
Terpenoids F. cavernosa Cavernolide TNF-α, NO and PGE2 production [160]
Axinella spp. 6-Cycloamphilectenes NO, PGE2 and TNF-α production [161]
2-Cycloamphilectenes Inhibit NF-КB pathway [161]
Psammocinia spp. Chromarols A-E Inhibition of 15-LOX [162]
Psammocinia spp. (8E, 13Z, 20Z)-strobilinin Anti-inflammatory
(7E, 13Z, 20Z)-felixinin Anti-inflammatory [158]
C. violacea Spongian Anti-inflammatory [163]
D. avara Avarol, avarone, Inhibition of eicosanoid release [164]
Spongiaquinone, ilimaquinone and depression of superoxide generation [165]
Dysidea spp. Dysidotronic acid Inhibited production of TNF-α, IL-1 PGE2, and LTB4 [166]
Plakortis spp. Plakolide A Inhibit iNOS [167]
D. elegans Cymopol DNA binding of NF-КB [168]
L. variabilis Manoalide, scalaradial Inhibited IL-1 and TNF-α [169]
F. cavernosa Cacospongiolide B Inhibited PLA2 [170]
Dysidea spp Dysidenones A-B Inhibited human synovial PLA2 [171]
L. variabilis Cladocorans A-B Inhibition of secretory PLA2 [172]
P. nigra Petrosa spongiolides Inhibitor of PLA2 [173]
P. nigra Petrosa spongiolide M Inhibited LTB4 levels [174]
Cacospongia spp. Scalaradial Inactivate the enzyme PLA2 [175]
G. sedna Homoscalarane Moderate activity to inhibit mammalian PLA2 [176]
Hyrtios sp. Puupehenone, hyrtenone A high potency against 12-human, 15-human and 
15-soybean LOX
[177]
C. linteiformis Cyclolinteinone iNOS and COX-2 protein expression in LPS-stimulated 
J774 macrophages
[178]
Callyspongia spp. Akaterpin Inhibitor of phosphatidylinositol-specific Phospholipase C [179]
Steroids C. lissosdera Clathriol In vitro anti-inflammatory activity against human 
neutrophil and rat mast cells
[180]
Euryspongia spp. Petrosterol, 3β-hydroxy-26-nor-
campest-5-en-25 oic acid
Against 6-keto-PGF1α release in a human keratinocyte 
cell line HaCaT
[181]
Alkaloids X. testudinaria Hymenialdisine Inhibitor of NF-КB and ILs production [182]
Agelas spp. Nagelamides A-H NF-КB in inflammatory diseases [183]
S. flabellate Stylissadines A-B Antiinflammatory activity [184]
Table 5. Anti-inflammatory compounds from marine sponges and their effects.
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analogs in which the quinine structure was converted to quinol dimethyl ether did not inhibit 
the Ca2+ ATPase activity [186]. The protein tyrosine kinase (PTK) inhibitory activities of halena-
quinone, halenaquinol, and 14-methoxyhalenaquinone were the most remarkable with IC
50
 
values <10 mm. The other analogs was either less potent or inactive, and a rationalization 
for this SAR pattern was also reported [187]. Xestoquinone also showed significant protein 
kinase inhibitory activity toward Pfnek-1, a serine/threonine malarial kinase, with an IC
50
 
value of ca. 1 mm, and moderate activity toward PfPK5, a member of the cyclin-dependent 
kinase (CDK) family [188]. Adociaquinone B and 3-ketoadociaquinone B were the most potent 
inhibitors of the Cdc25 B phosphatase inhibitory activities, and the dihydro-benzothiazine 
dioxide in compounds Adociaquinone A, Adociaquinone B, 3-Ketoadociaquinone A, and 
3-Ketoadociaquinone B appeared to be an important structural feature for this enhanced activ-
ity. Four cyclostellettamines, cyclostellettamine A, cyclostellettamine G, dehydrocyclostellet-
tamine D and dehydrocyclostellettamine E inhibited histone deacetylase derived from K562 
human leukemia cells with IC
50
 values ranging from 17 to 80 mm [189]. Xestospongic acid ethyl 
ester (207) was found to inhibit the Na+/K+ ATPase [190]. Compounds are listed in Table 6.
8. Sponge-derived immunosuppressive compounds and their efficacy
Recently natural constituents isolated from marine sponges were tested for immunosuppres-
sive activities and in the end of 1980s, deep water marine sponges resulted in isolation of pure 
compounds with immunosuppressive properties. Two important compounds: 4a-merhyl-5a-
cholest-8-en-3~-ol and 4,5-dibromo-2-pyrrolic acid discovered by American scientist from deep 
water sponge Agelasfla bellrform is showed significant immunosuppressive activity. Both com-
pounds were found significantly active in suppression of the response of murine splenocytes 
in the two-way mixed lymphocyte reaction (MLR) with little to no demonstrable cytotoxicity 
at low doses [196]. Constituents isolated from the Aurora globostellata marine sponge showed 
Categories Species Active agents Enzyme-inhibitory References
Quinones X. exigua Halenaquinone Ca2+ ATPase activity [191]
X. exigua Xestoquinone Ca2+ and K+-ATPase activity [192]
X. sapra Halenaquinol Protein tyrosine kinase activity [193]
X. cf. carbonaria 14-Methoxyhalenaquinone Protein tyrosine kinase activity [187]
Xestospongia sp. Adociaquinone B Protein tyrosine kinase activity [194]
Xestospongia sp. 3-Ketoadociaquinone B Cdc25B phosphatase activity [195]
Xestospongia sp. Adociaquinone A Cdc25B phosphatase [194]
Xestospongia sp. 3-Ketoadociaquinone Cdc25B phosphatase [195]




Fatty acids X. testudinaria Xestospongic acid ethyl ester inhibit the Na+/K+ ATPase [190]
Table 6. Marine sponge-derived compounds showing enzyme-inhibitory activities.
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 immunomodulatory potential. The immunomodulatory potential was evaluated by oral admin-
istration of ethyl acetate extract of marine sponge (200 mg/kg) to Wistar rats and the results 
obtained showed that extracts exhibited immunosuppressant activity and can further be studied 
[197]. A recent investigation on an Indian marine sponge aimed to isolate and characterize bac-
teria with immunomodulatory and antimicrobial activity. Callyspongia difusa (Gulf of Mannar 
province) a marine sponge resulted in isolation of 10 marine bacterial strains which exhibited 
remarkable antagonistic activity against clinical bacterial pathogens. These findings suggested 
that the sponge associated bacterial strain Virgibacillus sp. can contribute the search for novel anti-
biotics to overcome infections and also for the production of potential immunomodulators [109].
9. Hypocholesterolemic compounds
In the last decade studies reported that marine sponges could have been a source of hypo-
cholesterolemic compounds. For example, lysophosphatidylcholines and lyso-PAF analogs 
derived from Spirastrella abata are reported as successful inhibitors of cholesterol biosynthesis 
in vitro study [198, 199]. Zhao et al. [200] extracted novel lysophosphatidylcholines from marine 
sponges with hypocholesterolemic properties and thereby aroused an interest of compounds 
from marine sponge due to short lifespan of conventional lysophosphatidylcholines in vivo.
10. Sponge–derived antibiotics
Also, over the years marine sponges are considered as a rich source of natural products and 
metabolites for antibiotics possessing strong inhibitory against bacteria, fungi and microbes. 
Several studies revealed that many natural bioactive components isolated from various marine 
sponges can be useful for the production of new antibiotics and antimicrobial drugs. In the 
recent years many scientific studies provided evidences for marine sponge metabolites with 
efficient antibiotic, antibacterials and antimicrobial properties. Purpuroines A-J, halogenated 
alkaloids isolated from Lotrochota purpurea marine sponge showed promising inhibitory activi-
ties against bacteria and fungi related diseases [201]. Haliclona sp. sponge from Korea resulted 
in isolation of novel cyclic bis-1,3-dialkylpyridiniums and cyclostellettamines, which showed 
moderate cytotoxic and antibacterial activities against A549 cell-line and Gram-positive strains, 
respectively [202]. A number of new alkaloids were isolated from the marine sponge Agelas 
mauritiana: (+)-2-oxo-agela-sidine C, (−)-8′-oxo-agelasine D,4-bromo-N-(butoxymethyl)-1H-
pyrrole-2-carboxamide, ageloxime B, and (−)-ageloxime D and some of these isolated compo-
nents exhibited antifungal activity against Cryptococcus neoformans, antileishmanial activity 
in vitro and antibacterial activity against S. aureus and methicillin-resistant S. aureus in vitro 
[203]. Extracts prepared from the sponge’s species Petromica citrina, Haliclona sp. and Cinachyrella 
sp. exhibited antibacterial activity against 61% of the coagulase-negative staphylococci (CNS) 
strains, including strains resistant to conventional antibiotics. P. citrina extracts showed the larg-
est spectrum of inhibitory activity. This current study according scientist shows potential of 
marine sponges to become new sources of antibiotics and disinfectants for the control of CNS 
involved in bovine mastitis in future [204]. Isolation of isonitriles ditepene from Cymbastela hoo-
peri, tropical marine sponge and the axisonitrile-3 sesquiterpene isolated Acanthella kletra, from 
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the tropical marine sponge were tested for series of bioassays antibacterial, antiphotosynthetic, 
antifouling, antialgal, antifouling, antialgal, antiphotosynthetic, antifungal, and antitubercu-
lar. The results showed majority of the tested compounds were active against at least two of 
the applied test systems [152]. Recently, sponge-derived actinomycetes and sediments isolated 
from marine sponge were tested for bioactive constituents with antifungal and antimicrobial 
activity. Out of 15 prepared active extract nine were found active against Enterococcus fascism 
(vancomycin-resistant) and Candida albicans multidrug-resistant [132], including strains resistant 
to conventional antibiotics. Thus the bacterial actinomycetes from marine sponges and other 
marine organisms have been proved prolific producers of pharmacologically active compounds. 
Literature studies revealed that 70% of naturally derived antibiotics which are currently in clini-
cal use have been derived from actinomycetes. In the recent study, Streptomyces sp. strains from 
Mediterranean sponges and secondary metabolite namely, cyclic depsipeptide valinomycin, 
indolocarbazole alkaloid staurosporine and butenolide, were screened for anti-infective activi-
ties. All the isolated compounds along with Streptomyces sp. exhibited antiparasitic activities. 
Researchers also claim the anti-infective potential of marine actinomycetes is very promising.
11. Marine sponges-derived antifouling and antibiofilm compounds
Bacterial biofilms are surface-attached microorganism’s communities that are protected by 
an extracellular matrix of biomolecules. Continuous use of chemical antifoulants resulted in 
increased tributyltin concentration and created extensive pollution problems in marine organ-
isms. Natural antifouling molecules from marine have been recently reviewed and researches 
hope that will provide more specific and less toxic antifouling activity in future. Antifouling 
compounds derived from sponges were found to be very effective, environmentally friendly 
biocides and less toxic [205]. In the last few years several studies were directed to find the 
most promising alternative technologies to antifouling in marine organisms, especially from 
sponges. In a recent study structurally different compounds containing 3-alkylpyridine moi-
ety were evaluated for antifouling potential. The compounds, namely haminols, saraine and 
3-alkylpyridinium salts extracted from Reniera sarai, Haliclona sp. and the mollusk Haminoea 
fusar is obtained by synthesis, showed very good antifouling potential larvae of the barnacle 
Amphibalanus amphitrite. Bromopyrrole or diterpene alkaloids derivatives isolated from Agelas 
linnaei and Ageles nakamurai Indonesian marine sponges exhibited cytotoxic activity. Moreover, 
agelasine derivatives inhibited settling of larvae of Balanus improvisus in an antifouling bioas-
say as well as the growth of planktonic forms of biofilm forming bacteria S. epidermidis [206].
12. Conclusion
Marine invertebrates (Porifera, Cnidaria, Mollusca, Arthropoda, Echinodermata, etc.) are con-
sidered as one of the major groups of biological organisms which gave huge number of natu-
ral products and secondary metabolites with interesting pharmacological properties and led in 
the formation of novel drugs. Among marine invertebrates, marine sponges (phylum: Porifera) 
is the most dominant responsible group for discovering significant number of natural compo-
nents, which has been used as template to develop therapeutic drugs. These natural  products 
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possesses vast range of therapeutic application, including antimicrobial, antihypertensive, antioxi-
dant, anticancer, anticoagulant, anti-inflammatory, immune modulator, and wound healing and 
other medicinal effects. Therefore, marine sponges are considered a rich source of chemical diver-
sity and health benefits for developing drug candidates, nutritional supplements, cosmetics, and 
molecular probes that can be supported to increase the healthy life span of humans. In this chapter 
we included the most important and biologically active marine sponge-derived compounds and 
presented selected studies of most important bioactive and promising natural products and sec-
ondary metabolites from marine sponges.
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